Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Accured Expenses (2017 - 2021)

Historic Change in Accured Expenses for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $1.2 million.

  • Cogent Biosciences' Change in Accured Expenses rose 25383.6% to $1.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.4 million, marking a year-over-year increase of 24587.59%. This contributed to the annual value of $16.0 million for FY2024, which is 9529.99% up from last year.
  • Latest data reveals that Cogent Biosciences reported Change in Accured Expenses of $1.2 million as of Q4 2021, which was up 25383.6% from $602000.0 recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Change in Accured Expenses ranged from a high of $3.7 million in Q2 2021 and a low of -$2.0 million during Q1 2021
  • In the last 5 years, Cogent Biosciences' Change in Accured Expenses had a median value of $396000.0 in 2017 and averaged $344500.0.
  • As far as peak fluctuations go, Cogent Biosciences' Change in Accured Expenses crashed by 25942.03% in 2020, and later soared by 84495.97% in 2021.
  • Over the past 5 years, Cogent Biosciences' Change in Accured Expenses (Quarter) stood at $454000.0 in 2017, then plummeted by 127.31% to -$124000.0 in 2018, then soared by 578.23% to $593000.0 in 2019, then plummeted by 227.49% to -$756000.0 in 2020, then skyrocketed by 253.84% to $1.2 million in 2021.
  • Its Change in Accured Expenses was $1.2 million in Q4 2021, compared to $602000.0 in Q3 2021 and $3.7 million in Q2 2021.